Human caliciviruses are among the most important causes of gastroenteritis. Despite the increasing awareness of these agents as a major cause of diarrheal illness, assays for the diagnosis of human calicivirus infection are not available to most clinical laboratories. There are also no effective antivirals available that can be used therapeutically or prophylactically for this infection. This project will focus on high throughput approaches to develop rapid diagnostic assays for the detection of human caliciviruses and high throughput assays to identify potentially effective antiviral agents. We hypothesize that the reagents and strategies developed in the previous project period to target shared epitopes can be optimized and used to develop broadly reactive diagnostic assays for these antigenically diverse viruses.
In Specific Aim 1, we will further optimize broadly-reactive reagents that can be used to make diagnostic assays for human caliciviruses. Studies in this aim will optimize single chain (scFv) antibodies with a range of binding specificities and monoclonal antibodies that recognize conserved epitopes, both of which were developed and characterized in the previous funding period.
In Specific Aim 2, we will develop broadly-reactive diagnostic assays for human caliciviruses. Rapid formats that will be useable in the field to detect human caliciviruses will be identified. High affinity, cross-reactive single chain and monoclonal antibodies characterized in specific aim 1 will be used in assays that require minimal sample preparation and yield a result in less than 30 minutes. Formats to be evaluated are those that have been used successfully for the detection of other human viruses and include solid-phase immunoassays, and latex agglutination assays. In Speciflc Aim 3, we propose to develop high throughput assays to screen agents for antiviral activity against human noroviruses. A high throughput screen for inhibitors ofthe viral protease will be used to identify inhibitor candidates from small molecule libraries. The results obtained from project 1 studies will lead to the availability of new assays for the diagnosis of these important enteric pathogens and the identification of antiviral agents with the potential to diminish the disease burden caused these agents.
Noroviruses are a major cause of diarrheal disease, affecting travelers (for example, those on cruise ships), young children, the elderiy. and other groups. However, there are no readily available tests for rapidly diagnosing infection, and there are no medicines available to treat or prevent such infections. This project will develop rapid diagnostic tests and will identify possible antiviral agents for norovirus infection.
|Qu, Lin; Murakami, Kosuke; Broughman, James R et al. (2016) Replication of Human Norovirus RNA in Mammalian Cells Reveals Lack of Interferon Response. J Virol 90:8906-23|
|Ettayebi, Khalil; Crawford, Sue E; Murakami, Kosuke et al. (2016) Replication of human noroviruses in stem cell-derived human enteroids. Science 353:1387-1393|
|Prasad, Bv Venkataram; Shanker, Sreejesh; Muhaxhiri, Zana et al. (2016) Antiviral targets of human noroviruses. Curr Opin Virol 18:117-25|
|Shanker, Sreejesh; CzakÃ³, Rita; Sapparapu, Gopal et al. (2016) Structural basis for norovirus neutralization by an HBGA blocking human IgA antibody. Proc Natl Acad Sci U S A 113:E5830-E5837|
|Ramani, Sasirekha; Neill, Frederick H; Opekun, Antone R et al. (2015) Mucosal and Cellular Immune Responses to Norwalk Virus. J Infect Dis 212:397-405|
|Kou, Baijun; Huang, Wanzhi; Neill, Frederick H et al. (2015) Norovirus Antigen Detection with a Combination of Monoclonal and Single-Chain Antibodies. J Clin Microbiol 53:3916-8|
|Ye, X; Van, J N; Munoz, F M et al. (2015) Noroviruses as a Cause of Diarrhea in Immunocompromised Pediatric Hematopoietic Stem Cell and Solid Organ Transplant Recipients. Am J Transplant 15:1874-81|
|Henning, Susan J; Estes, Mary K (2015) Women in Science: Hints for Success. Gastroenterology 149:10-3|
|Crawford, Sue E; Ajami, Nadim; Parker, Tracy Dewese et al. (2015) Mapping broadly reactive norovirus genogroup I and II monoclonal antibodies. Clin Vaccine Immunol 22:168-77|
|Hesse, Shayla; Neill, Frederick H; Estes, Mary K et al. (2015) Serological Responses to a Norovirus Nonstructural Fusion Protein after Vaccination and Infection. Clin Vaccine Immunol 23:181-3|
Showing the most recent 10 out of 75 publications